Swedencare AB (publ) Acquires Animal Pharmaceuticals Inc.

Swedencare Acquires Vetio Animal Health from Thompson Street Capital Partners

July 1, 2021

Veterinary

Swedencare AB has acquired Vetio Animal Health, a North American contract development and manufacturing organization (CDMO) focused on veterinary pharmaceuticals, supplements and dermatology products, from Thompson Street Capital Partners. Thompson Street supported Vetio's growth through facility expansions and the acquisition of TetraGenx; Swedencare intends to leverage Vetio's manufacturing capabilities to expand its pet healthcare product portfolio and supply capabilities in North America.

Dechra Pharmaceuticals Acquires Med-Pharmex from DW Healthcare Partners

August 30, 2022

Veterinary

Dechra Pharmaceuticals PLC has completed the acquisition of Med-Pharmex Holdings, Inc. from DW Healthcare Partners. The deal brings a US-based, fully integrated veterinary pharmaceutical manufacturer (Med-Pharmex) into Dechra's global animal-health platform to strengthen its manufacturing capabilities and North American footprint.

Nordic Capital Acquires Atlantic Street Capital's Stake in United Veterinary Care

April 23, 2021

Healthcare Services

Nordic Capital has agreed to invest in United Veterinary Care (UVC), acquiring the shareholdings controlled by Atlantic Street Capital and joining UVC's veterinary owner-practitioners as a major shareholder. UVC is a Palm Beach Gardens, Florida–based multi-location veterinary group operating more than 60 hospitals across 13 U.S. states with over 1,200 employees; the transaction supports the company's continued organic and acquisitive growth.

Veterinary Pharmaceutical Solutions Acquires Diamond Animal Health

January 18, 2024

Veterinary

Veterinary Pharmaceutical Solutions (VPS), a Granite Creek Capital Partners portfolio company, acquired Diamond Animal Health from Mars Corporation. Granite Creek supported the deal with a follow-on investment from its FlexCap II fund, creating an integrated animal health platform combining VPS's compounding capabilities with Diamond's contract manufacturing and vaccine production.

Vision Healthcare Acquires Svenskt Kosttillskott and New Care Supplements

November 20, 2025

Consumer Products

Vision Healthcare (an Avista Healthcare Partners portfolio company) has acquired Svenskt Kosttillskott, a leading Swedish e-commerce supplements retailer, and New Care Supplements BV, a Dutch nutraceutical brand. The add-on deals (New Care closed June 2025; Svenskt closed July 2025) strengthen Vision’s presence in the Netherlands and the Nordics and expand its D2C product offering and pan‑European distribution and digital capabilities; terms were not disclosed.

Pfizer Acquires Arena Pharmaceuticals

December 13, 2021

Pharmaceuticals

Pfizer Inc. agreed to acquire clinical-stage Arena Pharmaceuticals for $100 per share in an all-cash transaction valued at approximately $6.7 billion, creating a wholly owned subsidiary. The acquisition brings Arena's development-stage portfolio — including etrasimod and cardiovascular assets — into Pfizer's Inflammation & Immunology pipeline to accelerate clinical development and expand therapeutic capabilities.